Disease-causing mutation in extracellular and intracellular domain of FGFR1 protein: computational approach
- PMID: 23329143
- DOI: 10.1007/s12010-012-0061-6
Disease-causing mutation in extracellular and intracellular domain of FGFR1 protein: computational approach
Abstract
In-depth computationally based structural analysis of human fibroblast growth factor type 1 (FGFR1) protein carrying disease-causing mutation was performed in this study. Gain or loss of function due to missense mutations in FGFR1 is responsible for a variety of disorders including Kallmann syndrome, Apert syndrome, Pfeiffer syndrome, Crouzon syndrome, etc. The mutant model of the human FGFR1 protein was subjected to various in silico analysis, and most deleterious SNPs were screened out. Furthermore, docking and long molecular dynamics simulations were carried out with an intention of studying the possible impact of these mutations on the protein structure and hence its function. Analysis of various structural properties-especially of those of the functionally important regions: the extracellular immunoglobulin domain and intracellular Tyrosine kinase domain-gave some insights into the possible structural characteristics of the disease mutant and the wild-type forms of the protein. In a nutshell, compared to the wild-type protein, the mutant structures V273M and S685F are associated with significant changes, and the functionally important regions seem to adopt such structures that are not conducive for the wild-type-like functionality.
Similar articles
-
Disease-causing mutations in proteins: structural analysis of the CYP1B1 mutations causing primary congenital glaucoma in humans.Biophys J. 2006 Dec 15;91(12):4329-39. doi: 10.1529/biophysj.106.085498. Epub 2006 Sep 8. Biophys J. 2006. PMID: 16963504 Free PMC article.
-
Comparative functional analysis of two fibroblast growth factor receptor 1 (FGFR1) mutations affecting the same residue (R254W and R254Q) in isolated hypogonadotropic hypogonadism (IHH).Gene. 2013 Mar 1;516(1):146-51. doi: 10.1016/j.gene.2012.12.041. Epub 2012 Dec 28. Gene. 2013. PMID: 23276709
-
In silico profiling and structural insights of missense mutations in RET protein kinase domain by molecular dynamics and docking approach.Mol Biosyst. 2014 Mar 4;10(3):421-36. doi: 10.1039/c3mb70427k. Epub 2013 Dec 12. Mol Biosyst. 2014. PMID: 24336963
-
[From gene to disease; craniosynostosis syndromes due to FGFR2-mutation].Ned Tijdschr Geneeskd. 2002 Jan 12;146(2):63-6. Ned Tijdschr Geneeskd. 2002. PMID: 11820058 Review. Dutch.
-
Cellular signaling by fibroblast growth factor receptors.Cytokine Growth Factor Rev. 2005 Apr;16(2):139-49. doi: 10.1016/j.cytogfr.2005.01.001. Epub 2005 Feb 1. Cytokine Growth Factor Rev. 2005. PMID: 15863030 Review.
Cited by
-
Efficacy of futibatinib, an irreversible fibroblast growth factor receptor inhibitor, in FGFR-altered breast cancer.Sci Rep. 2023 Nov 18;13(1):20223. doi: 10.1038/s41598-023-46586-y. Sci Rep. 2023. PMID: 37980453 Free PMC article.
-
Genotype-protein phenotype characterization of NOD2 and IL23R missense variants associated with inflammatory bowel disease: A paradigm from molecular modelling, dynamics, and docking simulations.Front Med (Lausanne). 2023 Jan 10;9:1090120. doi: 10.3389/fmed.2022.1090120. eCollection 2022. Front Med (Lausanne). 2023. PMID: 36703890 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
